… In this scenario EVs might be linked to cardiovascular manifestations of the Covid-19 disease
… of Covid-19 and highlight potential strategies to control the extracellular signaling for future …

… participation of extracellular vesicles (EVs) in the pathogenesis of coronavirus infection, its
… with SARS-CoV-2 dissemination via vesicles and cell-origination markers, characterizing …

… for the development of vaccines against COVID-19. Along with the … coronavirus or controlling
the cytokine storm, we also discuss the obstacles to the clinical use of extracellular vesicles …

… coronavirus disease-19 (COVID-19) caused by the severe acute respiratory syndrome
coronavirus … platelet-derived extracellular vesicles (pEVs) in COVID-19-related immunothrombosis…

… A high rate of thrombotic events occurs in coronavirus disease-2019 (COVID-19) … coronavirus-2
(SARS-CoV-2). Here, we will discuss novel data regarding the role of EVs in COVID-19-…

… be implicated in producing long-covid symptoms. Here, we assess the role of extracellular
vesicles (EV) in regulating T cell function over several weeks post COVID-19 disease. We find …

… of coronavirus that appeared in 2019, SARS-CoV-2, is the causative agent of severe respiratory
disease, COVID-19, … be to use ACE2 + -small extracellular vesicles (sEVs). A competitive …

… The lethality of the COVID 19 pandemic became the trigger … On the other hand, considering
that COVID 19 is here to stay, … of the benefits offered by extracellular vesicles (EVs), …

… as new or persistent symptoms of COVID-19 beyond 4 weeks of acute … and post-acute
COVID-19 disease pathogenesis, identify … extracellular vesicles (EVs) from hospitalized COVID-19 …

… the relapse of the COVID-19 infection. Extracellular vesicles containing Covid-19 may be
a possible mechanism for the reappearance of the viral RNA in the recovered COVID-19 …